Insights

Platform Partnerships SyntheX’s ToRFLEx platform supports discovery of molecular glues and protein degraders, creating potential demand for research tools, assay technologies, and specialist services that strengthen its discovery workflows.

BMS Collaboration The Bristol Myers Squibb partnership, announced in 2022, includes potential payments of up to $550 million. Business development teams can explore complementary capabilities that support collaboration milestones, while recognizing that the maximum figure is contingent biobucks rather than guaranteed revenue.

Oncology Pipeline SyntheX applies its platform to an internal oncology pipeline as well as external collaborations. Vendors offering preclinical development, translational research, or oncology expertise may be relevant as programs advance.

Lean Biotech With 11 to 50 employees and $12 million in reported funding, SyntheX is a relatively small biotech that may value flexible, cost-effective offerings in areas such as cloud infrastructure, laboratory operations, and outsourced research.

Discovery Differentiation Its focus on protein protein interactions and previously uncharacterized binding sites differentiates SyntheX from traditional in vitro and in silico approaches. Sales outreach should emphasize solutions that improve complex target validation, screening, or data analysis rather than generic discovery claims.

Similar companies to SyntheX

SyntheX Tech Stack

SyntheX uses 8 technology products and services including Cloudflare, Wix, WordPress, and more. Explore SyntheX's tech stack below.

SyntheX's Email Address Formats

SyntheX uses at least 1 email format:
SyntheX Email FormatsExamplePercentage
FLast@synthexlabs.comJDoe@synthexlabs.com
100%

Frequently Asked Questions

What is SyntheX's phone number?

Minus sign iconPlus sign icon
You can contact SyntheX's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SyntheX's official website and social media links?

Minus sign iconPlus sign icon
SyntheX's official website is synthexlabs.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does SyntheX generate?

Minus sign iconPlus sign icon
As of October 2026, SyntheX's annual revenue is estimated to be $1M - $10M.

What is SyntheX's SIC code and NAICS code?

Minus sign iconPlus sign icon
SyntheX's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SyntheX have currently?

Minus sign iconPlus sign icon
As of October 2026, SyntheX has approximately 40 employees across 3 continents, including North America, Europe and South America. Key team members include Coo & Head Of Finance: T. L., Regional Manager: A. Z. and Lead Frontend Engineer: A. L. Explore SyntheX's employee directory with LeadIQ.

What industry does SyntheX belong to?

Minus sign iconPlus sign icon
SyntheX operates in the Biotechnology Research industry.

What technology does SyntheX use?

Minus sign iconPlus sign icon
SyntheX's tech stack includes Cloudflare, Wix, WordPress, Google Workspace, Mailchimp, Google Cloud, jQuery and Cloudflare Bot Management.

What is SyntheX's email format?

Minus sign iconPlus sign icon
SyntheX's email format typically follows the pattern of FLast@synthexlabs.com. Find more SyntheX email formats with LeadIQ.

How much funding has SyntheX raised to date?

Minus sign iconPlus sign icon
As of October 2026, SyntheX has raised $12M in funding. The last funding round occurred on Feb 10, 2024 for $5.2M.

When was SyntheX founded?

Minus sign iconPlus sign icon
SyntheX was founded in 2016.
SyntheX logo

SyntheX

Biotechnology ResearchCalifornia, United States11-50 Employees

SyntheX is a biotechnology company focused on precision drug discovery through synthetic biology. It has developed a platform that combines engineered genetic circuits with intracellular selection to identify novel compounds with mechanisms outside traditional screening methods. The company specializes in targeting protein–protein interactions and developing molecular glues for targeted protein degradation, enabling binding to previously uncharacterized sites on protein targets. Based in San Francisco, California, the company supports an internal oncology program and engages in external collaborations. In October 2022, Bristol Myers Squibb announced a partnership with SyntheX to pursue molecular glue degrader discovery, reflecting the company's active role in the field.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $12M

    SyntheX has raised a total of $12M of funding over 7 rounds. Their latest funding round was raised on Feb 10, 2024 in the amount of $5.2M as a Venture Round.

  • $1M - $10M

    SyntheX's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.